StockData
BioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM) stock

BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)

Close on Nov 20, 2026Market cap $11.34MP/E –Yield –

BioStem Technologies price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

BioStem Technologies's price to book ratio was 0.9× on Nov 11, 2026.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×–

More BioStem Technologies figures

See a number that looks wrong?